153 results
424B2
GRN
Barclays Bank PLC
29 Mar 24
Prospectus for primary offering
1:41pm
therapy. The company offers educational and training materials. Novo Nordisk markets worldwide.
Information filed by Novo Nordisk A with the SEC
424B2
GRN
Barclays Bank PLC
26 Mar 24
Prospectus for primary offering
4:23pm
, growth disorders, and hormone replacement therapy. The company offers educational and training materials. Novo Nordisk markets worldwide.
Information
424B2
GRN
Barclays Bank PLC
25 Mar 24
Prospectus for primary offering
10:00am
such as haemostatis management, growth disorders, and hormone replacement therapy. The company offers educational and training materials. Novo Nordisk markets
424B2
GRN
Barclays Bank PLC
15 Mar 24
Prospectus for primary offering
5:53pm
educational and training materials. Novo Nordisk markets worldwide.
Information filed by Novo Nordisk A with the SEC under the Exchange Act can
6-K
EX-99.1
GRN
Barclays Bank PLC
27 Jul 23
Current report (foreign)
10:45am
expense over total income. Compensation represents total staff costs less non-compensation items consisting of outsourcing, staff training, redundancy
6-K
EX-99.1
b9q 3cbvzo
28 Jul 22
Current report (foreign)
11:11am
20-F/A
vdyt27w9ve41 dt4
23 May 22
Annual report (foreign) (amended)
12:16pm
6-K
EX-99.1
qnnd9rb
28 Apr 22
Current report (foreign)
1:21pm
6-K
EX-99.1
nt0xqvvsx
28 Jul 21
Current report (foreign)
11:40am
6-K
weqxok8quye
18 Feb 21
Annual Financial Report
12:56pm
6-K
EX-99.1
ew0uzisswla03pmwaz22
29 Jul 20
Current report (foreign)
9:55am
6-K
onmfrfjj1s6ke3aea
13 Feb 20
Annual Financial Report
2:52pm
6-K
EX-99.1
1zjd4
1 Aug 19
Current report (foreign)
9:08am
6-K
EX-99.1
f4qjdoy yrw1g67yt
2 Aug 18
Current report (foreign)
12:27pm